Estuardo Aguilar-Cordova
Gründer bei CANDEL THERAPEUTICS, INC.
Vermögen: 22 Mio $ am 30.04.2024
Aktive Positionen von Estuardo Aguilar-Cordova
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CANDEL THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.01.2002 | - |
| Gründer | 01.01.2002 | - | |
| Vorstandsvorsitzender | 01.01.2002 | 01.09.2020 | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.09.2020 | 07.02.2022 |
Karriereverlauf von Estuardo Aguilar-Cordova
Ehemalige bekannte Positionen von Estuardo Aguilar-Cordova
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - | - |
Nemucore Medical Innovations, Inc.
 Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Direktor/Vorstandsmitglied | - | - |
| Corporate Officer/Principal | - | - |
Ausbildung von Estuardo Aguilar-Cordova
| California State University-Bakersfield | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
| Universidad Del Valle De Guatemala | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Guatemala | 2 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 2 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CANDEL THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Health Technology |
